As a result, many people in low- and middle-income countries die younger from CVDs and other non-communicable diseases, often in their most productive years².
Aware of these diagnostic challenges, we've designed solutions tailored specifically to assist in the treatment of women with CVD.
We understand that heart disease can manifest itself differently in women than in men. Physiological differences can make it difficult to detect in women. As a result, we've developed products and solutions designed to treat women's hearts differently.
We've also designed an interventional cardiovascular lab for low-resource settings, thus enabling clinicians to bring cost effective cardiac care to more women (and men) across the continent. This lab has a smaller footprint, a low cost of ownership/maintenance and requires less training to operate. It is built to withstand high workloads, typical of resource-constrained countries.
The lab is well suited to perform a wide variety of procedures in both rural and urban environments.
¹,² Cardiovascular diseases (CVDs), fact sheet No317, September 2012, WHO Media Centre